NCT07383454Not yet recruiting
Lung Cancer Screening in Population Who Had Never Smoked
Lung Cancer Screening in Population Who Had Never Smoked and the Validation of Lung Cancer Risk Prediction Model
Source: ClinicalTrials.gov · Last updated 3 Feb 2026
Brief summary (registry, in English)
Study design: prospective, single arm. Objectives: survey lung cancer detection rate of low-dose computed tomography (LDCT) screening in individuals who had never smoked. Participants will undergo questionnaires, and collecting specimens including blood, urine, and medical informations including results of pulmonary function tests, and LDCT screening upon inclusion. The participants will be followed up according to current standards of clinical practice.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 2500 (estimated)
- First submitted
- 26 Jan 2026
- Start date
- 1 Feb 2026
- Primary completion date
- Dec 2030
- Lead sponsor
- Chung Shan Medical University
- Diseases
- Lung cancer
- NCT number
- NCT07383454
What you commit to
- Study type: Interventional
- Planned participants: 2500
- From 1 Feb 2026 to the primary completion date, Dec 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of lung cancer, or a diagnosis of any malignancy other than skin cancer or cervical carcinoma in situ within the past five years.
Other
- Undergoing chest computed tomography (CT) scans within the past 18 months.
- Unexplained hemoptysis within the past one month.
- Unexplained weight loss exceeding 6 kilograms within the past one year.
- Pregnancy.
Who the study is looking for
- Individuals with no history of smoking.
- Aged 40 to 80 years.
- Willing to provide written informed consent and complete questionnaire assessments.
- After undergoing examinations, willing to provide relevant biological information, including but not limited to: blood samples, urine samples, pulmonary function test results, imaging data, and tissue specimens obtained from invasive biopsies or surgical procedures (if applicable).
Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.